amylase 83900 UNT / lipase 21000 UNT / protease 54700 UNT Delayed Release Oral Capsule [Pancreaze]
RxNorm concept 1806931, branded drug (sbd). Prescribable name: PANCREAZE 21,000 UNT / 83,900 UNT / 54,700 UNT Delayed Release Oral Capsule.
- RxCUI
- 1806931
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1806931 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Pancreaze (amylase 83,900 UNT / lipase 21,000 UNT / protease 54,7000 UNT) Delayed Release Oral Capsule; Pancreaze (amylases 83,900 UNT / endopeptidases 54,700 UNT / lipase 21,000 UNT) Delayed Release Oral Capsule
Related concepts
- lipase 21000 UNT (SCDC, consists of)
- amylase 83900 UNT (SCDC, consists of)
- protease 54700 UNT (SCDC, consists of)
- amylase 83900 UNT / lipase 21000 UNT / protease 54700 UNT [Pancreaze] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Pancreaze (BN, has ingredient)
- amylase 83900 UNT / lipase 21000 UNT / protease 54700 UNT Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1806931 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1806931 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1806931. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.